You are here
Vincere Biosciences, Inc.
Company Information
Information
UEI: UFN3TELC89N7
# of Employees: 7
Ownership Information
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Discovery and Development of USP30 inhibitors as Disease-Modifying Therapy for Parkinson's disease.
Amount: $251,987.00PROJECT SUMMARY/ABSTRACTThe proposed Phase I research is designed to establish the technical/scientific merit and feasibility of developing first/best-in-class, USP30 inhibitors for the treatment of P ...
SBIRPhase I2020Department of Health and Human Services National Institutes of Health